Guanchen Bai

Qingdao University - Department of Hepatology

SCHOLARLY PAPERS

2

DOWNLOADS

65

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) as Induction Treatment in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Phase 2, Multicenter Trial, Single-Arm Trial

Number of pages: 25 Posted: 07 Mar 2023
Handan Central Hospital - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Harrison International Peace Hospital - Department of Hematology, People Hospital of Xing Tai - Department of Hematology, People Hospital of Xing Tai - Department of Hematology, Sinopharm Tongmei General Hospital - Department of Hematology, Handan Central Hospital - Department of Hematology, Chengde Medical College - Department of Hematology, Handan Central Hospital - Department of Hematology, Handan Central Hospital - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Harrison International Peace Hospital, Harrison International Peace Hospital, People Hospital of Xing Tai - Department of Hematology, Sinopharm Tongmei General Hospital - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, First People's Hospital of Tianmen - Department of Hematology, Qingdao University - Department of Hepatology, Qingdao University - Department of Hepatology, First People's Hospital of Tianmen - Department of Hematology, Qingdao University - Department of Hepatology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology
Downloads 39 (951,941)

Abstract:

Loading...

Venetoclax, daunorubicin and cytarabine, induction treatment, acute myeloid leukemia

2.

Comparable Survival Outcomes in Hla-Matched and Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Patients Aged 40-50: A Cbmtr Registry-Based Propensity Score Matching Analysis Over the Last Decade

Number of pages: 20 Posted: 06 Dec 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, Zhejiang University of Traditional Chinese Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Hebei Yanda Lu Daopei Hospital - Department of Hematology, affiliation not provided to SSRN, Central South University, affiliation not provided to SSRN, Government of the People's Republic of China - Chinese PLA General Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the People's Republic of China - Medical Center of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai General Hospital, Hebei Yanda Lu Daopei Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Shandong Second Medical University, Cangzhou Central Hospital, affiliation not provided to SSRN, Government of the People's Republic of China - Center for Hematology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Xi'an Jiaotong University (XJTU) - Department of Hematology, affiliation not provided to SSRN, Zhongshan City People's Hospital, Beijing Gobroad Boren Hospital, Qingdao University - Department of Hepatology, affiliation not provided to SSRN, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, South China University of Technology - Department of Hematology and Peking University - Institute of Hematology
Downloads 26 (1,093,129)

Abstract:

Loading...

Aplastic anemia, hematopoietic stem cell transplantation, haploidentical donor, matched sibling donor